Found: 12
Select item for more details and to access through your institution.
Assessment of Drug Interaction Potential Between the Hepatitis C Virus Direct‐Acting Antiviral Agents Elbasvir/Grazoprevir and the Nucleotide Analog Reverse‐Transcriptase Inhibitor Tenofovir Disoproxil Fumarate.
- Published in:
- Clinical Pharmacology in Drug Development, 2019, v. 8, n. 7, p. 962, doi. 10.1002/cpdd.701
- By:
- Publication type:
- Article
Pharmacokinetic Interactions Between the Fixed‐Dose Combinations of Elvitegravir/Cobicistat/Tenofovir Disoproxil Fumarate/Emtricitabine and Elbasvir/Grazoprevir in Healthy Adult Participants.
- Published in:
- Clinical Pharmacology in Drug Development, 2019, v. 8, n. 7, p. 952, doi. 10.1002/cpdd.702
- By:
- Publication type:
- Article
Effect of tildrakizumab (MK‐3222), a high affinity, selective anti‐IL23p19 monoclonal antibody, on cytochrome P450 metabolism in subjects with moderate to severe psoriasis.
- Published in:
- British Journal of Clinical Pharmacology, 2018, v. 84, n. 10, p. 2292, doi. 10.1111/bcp.13670
- By:
- Publication type:
- Article
Vorapaxar, an oral PAR-1 receptor antagonist, does not affect the pharmacokinetics and pharmacodynamics of warfarin.
- Published in:
- European Journal of Clinical Pharmacology, 2012, v. 68, n. 11, p. 1509, doi. 10.1007/s00228-012-1271-0
- By:
- Publication type:
- Article
Population pharmacokinetics of molnupiravir in adults with COVID‐19: Lack of clinically important exposure variation across individuals.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2023, v. 12, n. 12, p. 1859, doi. 10.1002/psp4.13031
- By:
- Publication type:
- Article
Pharmacokinetics of Oral Posaconazole in Neutropenic Patients Receiving Chemotherapy for Acute Myelogenous Leukemia or Myelodysplastic Syndrome.
- Published in:
- Pharmacotherapy, 2008, v. 28, n. 10, p. 1223, doi. 10.1592/phco.28.10.1223
- By:
- Publication type:
- Article
Pharmacokinetics of Oral Posaconazole in Allogeneic Hematopoietic Stem Cell Transplant Recipients with Graft-versus-Host Disease.
- Published in:
- Pharmacotherapy, 2007, v. 27, n. 12, p. 1627, doi. 10.1592/phco.27.12.1627
- By:
- Publication type:
- Article
Effect of Oral Posaconazole on the Pharmacokinetics of Cyclosporine and Tacrolimus.
- Published in:
- Pharmacotherapy, 2007, v. 27, n. 6, p. 825, doi. 10.1592/phco.27.6.825
- By:
- Publication type:
- Article
A phase 1 pooled PK/PD analysis of bone resorption biomarkers for odanacatib, a Cathepsin K inhibitor.
- Published in:
- Journal of Pharmacokinetics & Pharmacodynamics, 2020, v. 47, n. 5, p. 473, doi. 10.1007/s10928-020-09699-9
- By:
- Publication type:
- Article
No Pharmacokinetic Interactions Between Elbasvir or Grazoprevir and Buprenorphine/Naloxone in Healthy Participants and Participants Receiving Stable Opioid Agonist Therapy.
- Published in:
- CTS: Clinical & Translational Science, 2018, v. 11, n. 6, p. 562, doi. 10.1111/cts.12565
- By:
- Publication type:
- Article
No Pharmacokinetic Interactions Between Elbasvir or Grazoprevir and Methadone in Participants Receiving Maintenance Opioid Agonist Therapy.
- Published in:
- CTS: Clinical & Translational Science, 2018, v. 11, n. 6, p. 553, doi. 10.1111/cts.12564
- By:
- Publication type:
- Article
Phase 1b/3 Pharmacokinetics and Safety Study of Intravenous Posaconazole in Adult Asian Participants at High Risk for Invasive Fungal Infections.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 4, p. 1697, doi. 10.1007/s12325-021-02012-1
- By:
- Publication type:
- Article